Research

PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.

Research to Look at Psychedelics for Autism Treatment

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.

FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

The FDA has approved a novel study allowing therapists who treat PTSD to take MDMA to better understand the treatment benefits.

Algernon to Become the First Company in the World to Study DMT for Stroke Patients

Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.

FDA Greenlights Ketamine for Parkinson's Disease Treatment

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.

Could Psychedelics Cure Color Blindness? New Data Sees a Bright Future

Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin.

The World Boxing Council Is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

Treating traumatic brain injury with psychedelics will get a closer study in a partnership between the World Boxing Council and Wesana Health.

Oregon’s Democratic Party Endorses Legalization of Psilocybin

Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression

In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.

MDMA Study Finds More Than 60% Success Rate in PTSD Patients

New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.

NIMH Addresses Critical Need for Fast-Acting Interventions for Severe Suicide Risk

NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, Esketamine

New treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.

MindMed’s Project Angie to Explore LSD for Pain Conditions

MindMed’s Project Angie to Explore LSD for Chronic Pain Treatment

Psychedelic life sciences company MindMed is exploring LSD as a means of pain management.

Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSD

The first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.

Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.

Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.

Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic Breathwork

Stanislav Grof is one of the earliest pioneers in psychedelics and holotropic breathwork.

Interactive Dreaming May Hold Similar Therapeutic Potential As Psychedelics

Interactive or lucid dreaming may be as beneficial for mental health as lucid dreaming, new research finds.

Study Looking at Ibogaine for Opioid Addiction

New Study Will Look At Ibogaine Treatment for Opioid Addiction

A potent tool in the battle against opioid addiction, ibogaine treatment is the subject of a new study in the UK.

Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair, Study Finds

New research points to a connection between psilocybin mushrooms and creativity.

Psilocybin As Effective as Lexapro in Treating Depression: Study

The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.

Lower Doses of Psilocybin May Still Have Antidepressant Effects

Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.

Can You Predict a ‘Bad’ Psychedelic Trip? And Can You Stop One Once It Starts?

For all the benefits in taking psychedelic substance like psilocybin, there is the risk of having a bad trip.

Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse

Adults with depression who were abused or neglected as children responded better to intravenous ketamine therapy than depressed adults who were not mistreated, according to a poster presentation and discussion at the recent Anxiety and Depression…

The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.

Yale to Study Psilocybin for Cluster Headaches

Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.

Study Investigates Optimal Dosing for MDMA

Potential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.

UCSF Launches New Psychedelic Research Division

Psychedelic research is coming to the University of California in a new division to study MDMA.

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?

Use of Psychedelic Shows Correlation With Better Overall Physical Health

Use of Psychedelics Show Correlation With Better Overall Physical Health

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.

Are Stereotypes Around Psychedelics Slowing Down Research?

Psychedelics come with history as party drugs. Are these stigmas slowing down progress?

Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

New Research Investigates Psilocybin as OCD Treatment

Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic use may help to decrease the risk of hypertension, according to new research.

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.

MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.

Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.

These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

Business, Research

Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.

Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.

Algernon to Investigate DMT Microdose for Stroke Treatment

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.

Ketamine Therapy May Help Slow Progression of ALS

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.

Beckley Psychtech Explores Psilocybin for Headache Treatment

Beckley Psytech Explores Psilocybin for Headache Treatment

A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.

Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.

Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Business, Research

NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.

Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy

A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.

New Research Finds Significant Role of Expectations in Psychedelic Microdosing Benefits

Are the benefits of psychedelic microdosing all in our heads? A new study looks at the results compared to placebo. The results might shock you.

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

Business, Research, Treatment

Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.

Psychedelics Cause Ego Death: What You Need to Know

One aspect of the psychedelic experience is something called ego death. Can it help people with mental health issues?

Professor Michiel van Elk Awarded More Than $970,000 Grant to Study Psychedelics

Professor Michiel van Elk of the University of Leiden has been awarded a nearly $1 million to study psychedelics.

First-Ever DMT Trials for Depression Approved in UK

The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.

Psychedelics and Schizophrenia: What’s the Link?

Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years before Swiss chemist Albert Hofmann decided to reopen research on this strange chemical. One day while at work at Sandoz Laboratories, he accidentally let LSD…

Psilocybin Four Times More Effective Than Antidepressants, Study Finds

New research into the benefits of psilocybin point to significant improvements for those suffering with depression. The new study, published in the journal JAMA Psychiatry found the impact of psilocybin was “more than four…

Microdosing Results In Mental Health Benefits for 79% Of Users: Survey

A new study links microdosing psychedelics to improved mental health in the vast majority of subjects. Microdosing involves taking small amounts of substances such as LSD or psilocybin over an extended period of time. The low-level dosages…

Psychedelics and Neuroplasticity: Molding a New Way of Thinking

Can psychedelics improve neuroplasticity in the brain? Psychedelics are making a comeback. Over the past decade we have seen some unprecedented results in modern psychiatry. From psilocybin treating depression, to LSD treating alcoholism.…

Are You a Good Candidate for a Psychedelic Study?

Could you be a candidate for taking part in a psychedelic study? What impact could it have on your mental health? Clinical studies are crucial to medical knowledge. They help researchers obtain valuable information about the safety…

Researchers Replicate Ketamine Effects By Mimicking Brain Rhythms

Psychedelic-like states of consciousness may soon be achievable without the need for substances like ketamine, psilocybin, or MDMA. A new study, published in the journal Nature, suggests the ability to replicate these altered states of consciousness…

How Psychedelics Are Helping Women Beat Breast Cancer

In 2012, author Erica Rex had her first experience with psilocybin. She was three years into a breast cancer diagnosis. Could psychedelics hold the cure? Or at least, part of it? Research is beginning to point to a possible link. Rex volunteered…

Can Psychedelics Improve Your Sex Life?

Research into psychedelics shows promise in treating a growing number of ailments including treatment-resistant depression, anxiety, PTSD, and post-operative pain. But it may do you some good in the bedroom, too, according to new scientific…

5-MeO-DMT: Experiencing the Therapeutic God Molecule

Rafael was apprehensive at first. Sitting on a yoga mat facing the setting sun, he whispered to his wife, “I’m scared.” R5-MeO-DMT was a religious experience for Rafael. Recounting his second journey on the outlawed chemical on 5Hive,…

MindMed and NYU Team Up for $5 Million Psychedelic Research and Training Program

Leading psychedelic biotech company, MindMed, has partnered with NYU’s Langone Health center. Together, they’ll work to develop the NYU Langone Health Psychedelic Medicine Research Training Program. It will lead to a psychedelic research…

Dr. Bronner’s Soap Donates $3 Million to Psychedelic Research and Advocacy

Popular natural soap brand Dr. Bronner’s has launched a campaign to promote psychedelic therapy. ‍ Dubbed the “Heal Soul” campaign, Dr. Bronner’s hopes to draw attention to public education and advocacy work helping make psychedelic-assisted…

Johns Hopkins Center for Psychedelic & Consciousness Research Interview

https://www.youtube.com/watch?v=oJiDDATv9uU&feature=emb_logo

Octopuses On MDMA Want to Snuggle Just Like You

In the Netflix documentary My Octopus Teacher, filmmaker Craig Foster befriends an octopus in the Atlantic waters near his home. Over a year, he visits her nearly every day. Their bond, even though octopuses are solitary animals, becomes…

Johns Hopkins to Build World’s Largest Registry on Psilocybin Use

The John Hopkins Center for Psychedelic and Consciousness Research (CPCR) will create the world’s largest registry on psilocybin use, the center announced last month. In a partnership with Unlimited Sciences, a psychedelic research nonprofit,…

Understanding Ayahuasca: Combining Clinical Insights With Personal Experience

The traditional Amazonian psychedelic concoction, Ayahuasca, has begun to receive widespread attention for its powerfully therapeutic benefits. As countless people from across the globe travel to destinations like Mexico and South America to…

MAPS Brings In $30 Million to Fund MDMA Research

When the story is written about how psychedelic medicine emerged into the mainstream, there will be a chapter about August of 2020. Because the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) just made history. Earlier…

Microdosing Psychedelics Recent Rediscovery

Microdosing Psychedelics: A Recent Rediscovery

James Fadiman begins by asking, “How many of you have never had any psychedelic experience?” He’s speaking to a Science And Nonduality (SAND) conference, a group that assembles scientists, philosophers, sages and mystics to explore…

Can a Compound in ‘Magic’ Mushrooms Cure Social Anxiety?